Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 380.2M | $ 263.63M | $ 116.58M |
3/31/2025 | $ 310.18M | $ 255.04M | $ 55.13M |
12/31/2024 | $ 341.58M | $ 282.98M | $ 58.6M |
9/30/2024 | $ 369.02M | $ 295.57M | $ 73.46M |
6/30/2024 | $ 557.93M | $ 463M | $ 94.93M |
3/31/2024 | $ 627.48M | $ 538.3M | $ 89.17M |
12/31/2023 | $ 475.63M | $ 331.77M | $ 143.86M |
9/30/2023 | $ 444.37M | $ 239.66M | $ 204.71M |
6/30/2023 | $ 385.48M | $ 169.44M | $ 216.04M |
3/31/2023 | $ 315.93M | $ 123.41M | $ 192.52M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for COHERUS ONCOLOGY INC is calculated as follows: AssetsC [ $ 726.92M ] - LiabilitesC [ $ 133.43M ]
(=) Working Capital [ $ 593.49M ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.79K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.42M |
median | $ 32.11M |
std | $ 173.65M |